Compounds > malondialdehyde
Page last updated: 2024-08-21

malondialdehyde and Placenta Diseases

malondialdehyde has been researched along with Placenta Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barja, P; Bosco, C; Buffet, C; Díaz, E; Morales, P; Parra-Cordero, M; Rodrigo, R; Terra, R1
Antal, L; Bodog, A; Bodog, F; Micle, O; Muresan, M1
Laurini, RN; Olofsson, P; Saldeen, P1
Calay, Z; Madazli, R; Ocak, V; Tuten, A; Uludag, S; Uzun, H1

Other Studies

4 other study(ies) available for malondialdehyde and Placenta Diseases

ArticleYear
VEGF in the muscular layer of placental blood vessels: immuno-expression in preeclampsia and intrauterine growth restriction and its association with the antioxidant status.
    Cardiovascular & hematological agents in medicinal chemistry, 2010, Volume: 8, Issue:2

    Topics: Antioxidants; Blood Vessels; Female; Fetal Growth Retardation; Humans; Immunohistochemistry; Infant, Newborn; Iron; Malondialdehyde; Muscle, Smooth, Vascular; Oxidative Stress; Placenta Diseases; Pre-Eclampsia; Pregnancy; Vascular Endothelial Growth Factors

2010
The influence of homocysteine and oxidative stress on pregnancy outcome.
    Journal of medicine and life, 2012, Feb-22, Volume: 5, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Ceruloplasmin; Female; Homocysteine; Humans; Hyperhomocysteinemia; Malondialdehyde; Oxidative Stress; Placenta Diseases; Pregnancy; Pregnancy Outcome; Romania; Uric Acid

2012
Signs of platelet activation, but not lipid peroxidation, in fetal blood associated with functional and structural umbilicoplacental lesions in pregnancies complicated by impaired glucose metabolism.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2002, Volume: 12, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; C-Peptide; Embryonic and Fetal Development; Epoprostenol; Female; Fetal Blood; Glucose Intolerance; Glycated Hemoglobin; Humans; Lipid Peroxidation; Malondialdehyde; Placenta; Placenta Diseases; Platelet Activation; Pregnancy; Pregnancy in Diabetics; Thromboxane A2; Thromboxane B2; Umbilical Arteries; Umbilical Veins

2002
The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls.
    Gynecologic and obstetric investigation, 2008, Volume: 65, Issue:4

    Topics: Adult; Biomarkers; Case-Control Studies; Diabetes, Gestational; Erythropoietin; Female; Fetal Blood; Humans; Incidence; Malondialdehyde; Neovascularization, Physiologic; Oxidative Stress; Placenta; Placenta Diseases; Pregnancy; Vascular Endothelial Growth Factor A

2008